ARS Pharmaceuticals - 53 Year Dividend History | SPRY
Historical dividend payout and yield for ARS Pharmaceuticals (SPRY) since 1971. The current TTM dividend payout for ARS Pharmaceuticals (SPRY) as of November 22, 2024 is $0.00. The current dividend yield for ARS Pharmaceuticals as of November 22, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Drug Manufacturing |
$1.361B |
$0.000B |
|
ARS Pharmaceuticals Inc. is dedicated to empowering at-risk patients and caregivers to better protect themselves from severe allergic reactions which could lead to anaphylaxis. The company is developing neffy(TM) an intranasal epinephrine product in clinical development for patients and their caregivers with Type I allergic reactions including food, medications and insect bites. ARS Pharmaceuticals Inc., formerly known as Silverback Therapeutics Inc., is based in SEATTLE.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
